Literature DB >> 8141788

Periplasmic expression of human interferon-alpha 2c in Escherichia coli results in a correctly folded molecule.

T Voss1, E Falkner, H Ahorn, E Krystek, I Maurer-Fogy, G Bodo, R Hauptmann.   

Abstract

Human interferon-alpha 2c (IFN-alpha 2c) was produced in Escherichia coli under the control of the alkaline phosphatase promoter using a periplasmic expression system. Compared with other leader sequences, the heat-stable enterotoxin II leader of E. coli (STII) resulted in the highest rate of correct processing as judged by Western-blot analysis. The fermentation was designed as a batch-fed process in order to obtain a high yield of biomass. The processing rate of IFN-alpha 2c could be increased from 25% to more than 50% by shifting the fermentation pH from 7.0 to 6.7. IFN-alpha 2c extracted from the periplasm was purified by a new four-step chromatographic procedure. Whereas cytoplasmically produced IFN-alpha 2c does not have its full native structure, IFN-alpha 2c extracted from the periplasm was found to be correctly folded, as shown by c.d. spectroscopy. Peptide-map analysis in combination with m.s. revealed the correct formation of disulphide bridges. N-terminal sequence analysis showed complete removal of the leader sequence, creating the authentic N-terminus starting with cysteine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141788      PMCID: PMC1137919          DOI: 10.1042/bj2980719

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Sequence of the gene for alkaline phosphatase from Escherichia coli JM83.

Authors:  H Shuttleworth; J Taylor; N Minton
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

2.  Nucleotide sequence of the gene for heat-stable enterotoxin II of Escherichia coli.

Authors:  R N Picken; A J Mazaitis; W K Maas; M Rey; H Heyneker
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

3.  Construction of expression plasmids producing high levels of human leukocyte-type interferon in Escherichia coli.

Authors:  E Dworkin-Rastl; P Swetly; M B Dworkin
Journal:  Gene       Date:  1983-03       Impact factor: 3.688

4.  Nucleotide sequence of the alkaline phosphatase gene of Escherichia coli.

Authors:  C N Chang; W J Kuang; E Y Chen
Journal:  Gene       Date:  1986       Impact factor: 3.688

5.  Trans-complementable copy-number mutants of plasmid ColE1.

Authors:  A J Twigg; D Sherratt
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

6.  Human leukocyte interferon produced by E. coli is biologically active.

Authors:  D V Goeddel; E Yelverton; A Ullrich; H L Heyneker; G Miozzari; W Holmes; P H Seeburg; T Dull; L May; N Stebbing; R Crea; S Maeda; R McCandliss; A Sloma; J M Tabor; M Gross; P C Familletti; S Pestka
Journal:  Nature       Date:  1980-10-02       Impact factor: 49.962

7.  Characterization of the gene encoding heat-stable toxin II and preliminary molecular epidemiological studies of enterotoxigenic Escherichia coli heat-stable toxin II producers.

Authors:  C H Lee; S L Moseley; H W Moon; S C Whipp; C L Gyles; M So
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Production of monoclonal antibodies to human IFN-alpha and their use for analysis of the antigenic composition of various natural interferons.

Authors:  G R Adolf; G Bodo; P Swetly
Journal:  J Cell Physiol Suppl       Date:  1982

9.  Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.

Authors:  G R Adolf
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

10.  Three-dimensional crystal structure of recombinant murine interferon-beta.

Authors:  T Senda; T Shimazu; S Matsuda; G Kawano; H Shimizu; K T Nakamura; Y Mitsui
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

View more
  1 in total

1.  Expression of active recombinant pallidipin, a novel platelet aggregation inhibitor, in the periplasm of Escherichia coli.

Authors:  B Haendler; A Becker; C Noeske-Jungblut; J Krätzschmar; P Donner; W D Schleuning
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.